文献速递垂体与肾上腺疾病性腺与生殖内分泌

妊娠期原发性醛固酮增多症的评估与管理:一项病例对照研究

Assessment and Management of Primary Aldosteronism in Pregnancy: A Case-Control Study.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

在澳大利亚悉尼都会区医院网络开展的病例对照研究,将60例单胎妊娠(20例原发性醛固酮增多症、20例高危、20例低危)匹配比较。原发性醛固酮增多症组较高危组需要更多降压药、产后住院时间更长(均P=0.02),但子痫前期发生率相似,新生儿不良结局无差异。

要点

  • 原发性醛固酮增多症孕妇较高危对照需要更多降压药,产后住院时间更长,两者P=0.02。
  • 原发性醛固酮增多症组与高危组的子痫前期预防用药比例及子痫前期发生率相似。
  • 校正多个因素后,原发性醛固酮增多症与子痫前期发生无独立关联。

核心结论

  • 原发性醛固酮增多症孕妇较高危匹配孕妇需要更多降压药且产后住院时间更长,但子痫前期发生率相似。
  • 新生儿重症监护入住率及新生儿不良结局无差异。

研究设计与样本

  • 在澳大利亚悉尼都会区医院网络开展病例对照试验。
  • 纳入盐负荷抑制试验阳性、单胎妊娠且妊娠20周后分娩的原发性醛固酮增多症孕妇,与高危和低危妊娠孕妇匹配。
  • 共纳入59名妇女的60次妊娠:原发性醛固酮增多症20例、高危20例、低危20例。

主要发现

  • 原发性醛固酮增多症组孕前服用降压药数量与高危组相似。
  • 原发性醛固酮增多症组与高危组接受子痫前期预防用药的比例及发生子痫前期的比例相似。
  • 校正多个因素后,原发性醛固酮增多症与子痫前期发生无独立关联。
  • 原发性醛固酮增多症组较高危组降压药需求更高、产后住院时间更长(均P=0.02)。
  • 新生儿不良结局无差异;4名妇女妊娠期服用依普利酮,未观察到不良效应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Primary aldosteronism (PA) is a common secondary cause of hypertension. Literature regarding PA in pregnancy has demonstrated poor outcomes. OBJECTIVE: Compare the management and outcomes of PA in pregnancy to both high and low-risk matched controls. METHODS: This was a case-control trial conducted in a network of metropolitan hospitals in Sydney, Australia. PA women (positive salt suppression test) with singleton pregnancies delivered after 20 weeks' gestation were matched to women with high- and low-risk pregnancies. Management outcomes included pre-eclampsia prophylaxis and antihypertensive medications required prenatally, antenatally, and postnatally. Maternal outcomes included incidence of pre-eclampsia, gestational diabetes, hypokalemia, mode of delivery, and length of stay postpartum. Neonatal outcomes included gestation, birthweight, intensive care unit admission, and length of stay. RESULTS: Fifty-nine women with 60 pregnancies were included (20 PA, 20 high risk, and 20 low risk). The number of antihypertensive medications women with PA took prepregnancy was similar to the high-risk group. A similar proportion of women in the PA and high-risk groups were prescribed pre-eclampsia prophylaxis and developed pre-eclampsia. Even after adjustment for several factors, PA was not independently associated with pre-eclampsia development. Women with PA had higher antihypertensive requirements and a longer stay in hospital postpartum than the high-risk group (both P = .02). There was no difference in neonatal adverse outcomes. Four women took epleronone during pregnancy without any adverse effects noted. CONCLUSION: Women with PA required more antihypertensives and had a longer postpartum length of stay than matched high-risk women, but similar rates of pre-eclampsia. There was no difference in the rate of neonatal intensive care admissions or adverse outcomes for neonates.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Downie E, Shanmugalingam R, Hennessy A, et al. Assessment and Management of Primary Aldosteronism in Pregnancy: A Case-Control Study. J Clin Endocrinol Metab. 2022. PMID: 35569086. doi:10.1210/clinem/dgac311

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。